in the Canadian rare disease treatment ecosystem. Through its strategic partnerships, Médunik Canada commercializes and develops its own orphan drugs thereby offering new therapeutic options to improve the health and quality of life of Canadians suffering from rare diseases.
An illness that affects a small percentage of the population, thereby limiting research, clinical expertise and patient access to effective treatment options
A medication or other medicinal product used to treat a rare disease or disorder
Medunik Canada is dedicated to providing Canadians suffering from rare diseases with access to orphan drugs that are not currently available in Canada. We make these treatment options available by building strategic partnerships with international companies to bring their products to the Canadian market.
10 MG TABLETS
Now available to prescribe and covered by:
*Coverage may vary depending on the plans specific criteria.
